TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase

(2014) Dongzhu Duan et al.   FREE RADICAL BIOLOGY AND MEDICINE

Tissue thioredoxin reductase-1 expression in astrocytomas of different grades

(2014) Hasan Esen et al.   JOURNAL OF NEURO-ONCOLOGY

Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma

(2013) Leilei Chen et al.   NATURE MEDICINE

Overexpression of CENP-H as a novel prognostic biomarker for human hepatocellular carcinoma progression and patient survival

(2013) GUIFANG LU et al.   ONCOLOGY REPORTS

Thioredoxin reductase 1 deficiency enhances selenite toxicity in cancer cells via a thioredoxin-independent mechanism

(2012) Ryuta Tobe et al.   BIOCHEMICAL JOURNAL

Thioredoxin reductase 1 protects against chemically induced hepatocarcinogenesis via control of cellular redox homeostasis

(2012) Bradley A. Carlson et al.   CARCINOGENESIS

Thioredoxin and thioredoxin reductase: Current research with special reference to human disease

(2010) Arne Holmgren et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunction

(2010) Robyn L. Poerschke et al.   BIOCHEMICAL PHARMACOLOGY

Upregulation of thioredoxin reductase 1 in human oral squamous cell carcinoma

(2010) Uzawa   ONCOLOGY REPORTS

Expression profiles of thioredoxin family proteins in human lung cancer tissue: correlation with proliferation and differentiation

(2009) Aristi P Fernandes et al.   HISTOPATHOLOGY

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

(2009) Dunyaporn Trachootham et al.   NATURE REVIEWS DRUG DISCOVERY